Evaluating systematic reanalysis of clinical genomic data in rare disease from single center experience and literature review

摘要

Our primary aim was to evaluate the systematic reanalysis of singleton exome sequencing (ES) data for unsolved cases referred for any indication. A secondary objective was to undertake a literature review of studies examining the reanalysis of genomic data from unsolved cases.